SCHOTT Pharma AG & Co. KGaA

1SXP

DE000A3ENQ51

Medical Equipment, Supplies & Distribution

Market Closed - Xetra Other stock markets 09:05:26 02/07/2024 pm IST			Pre-market 11:02:01 am
31.34 ^EUR	+0.51%		31.25	-0.29%

02/07	Deutsche Bank raises target for Schott Pharma to 37 euros - 'Buy'	DP
02/07	SCHOTT PHARMA : Deutsche Bank reiterates its Buy rating	ZD

SCHOTT PHARMA : Berenberg gives a Neutral rating

July 01, 2024 at 12:01 pm IST

Victoria Lambert from Berenberg retains his Neutral opinion on the stock. The target price is lowered from EUR 38 to EUR 32.

Latest news about SCHOTT Pharma AG & Co. KGaA

Deutsche Bank raises target for Schott Pharma to 37 euros - 'Buy'	02/07	DP
SCHOTT PHARMA : Deutsche Bank reiterates its Buy rating	02/07	ZD
New semester, new state of mind	01/07
SCHOTT PHARMA : Jefferies remains Neutral	01/07	ZD
SCHOTT PHARMA : Berenberg gives a Neutral rating	01/07	ZD
German Stocks Rise for Second Session	28/06	DJ
SCHOTT PHARMA : UBS remains Neutral	28/06	ZD
SCHOTT Pharma AG & Co. KGaA Reports Earnings Results for the Half Year Ended March 31, 2024	28/06	CI
German Stocks Reverse Two-Session Losing Streak	27/06	DJ
Schott Pharma recovers - confirmation of annual targets is well received	27/06	DP
Schott Pharma expands production - focus on USA	27/06	DP
SCHOTT PHARMA : Jefferies sticks Neutral	27/06	ZD
SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion	05/06	CI
SCHOTT PHARMA : Berenberg reiterates its Neutral rating	28/05	ZD
Deutsche Bank Research lowers target for Schott Pharma - 'Buy'	21/05	DP
SCHOTT PHARMA : Receives a Buy rating from Deutsche Bank	21/05	ZD
UBS lowers target for Schott Pharma to 33 euros - 'Neutral'	20/05	DP
SCHOTT PHARMA : UBS reiterates its Neutral rating	20/05	ZD
Barclays lowers Schott Pharma target to 25 euros - 'Equal Weight'	15/05	DP
SCHOTT PHARMA : Deutsche Bank reiterates its Buy rating	15/05	ZD
Flood of figures puts investors in a buying mood - US inflation ahead	15/05	RE
SCHOTT PHARMA : Barclays remains Neutral	15/05	ZD
Schott Pharma falls sharply - 'High dependence on end markets'	15/05	DP
SCHOTT PHARMA : Gets a Neutral rating from UBS	15/05	ZD
Schott Pharma warns of weak syringe sales - share price slide	15/05	DP

Chart SCHOTT Pharma AG & Co. KGaA

Duration

Period

More charts

SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The Company's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.

Sector

Medical Equipment, Supplies & Distribution

Calendar

29/08/2024 - Q3 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for SCHOTT Pharma AG & Co. KGaA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

31.34 EUR

Average target price

34.21 EUR

Spread / Average Target

+9.15%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SCHOTT PHARMA AG & CO. KGAA	-6.73%	506.79Cr
ABBOTT LABORATORIES	-6.24%	18TCr
MEDTRONIC PLC	-6.08%	9.92TCr
BECTON, DICKINSON AND COMPANY	-5.98%	6.63TCr
DEXCOM, INC.	-9.35%	4.47TCr
CENCORA, INC.	+8.34%	4.38TCr
HOYA CORPORATION	+10.52%	4.2TCr
METTLER-TOLEDO INTERNATIONAL, INC.	+11.88%	2.9TCr
WEST PHARMACEUTICAL SERVICES, INC.	-8.38%	2.35TCr
TERUMO CORPORATION	+15.99%	2.41TCr

Other Medical Equipment, Supplies & Distribution

SCHOTT Pharma AG & Co. KGaA

Equities

1SXP

DE000A3ENQ51

Medical Equipment, Supplies & Distribution

SCHOTT PHARMA : Berenberg gives a Neutral rating

Latest news about SCHOTT Pharma AG & Co. KGaA

Chart SCHOTT Pharma AG & Co. KGaA

Company Profile

Income Statement Evolution

Ratings for SCHOTT Pharma AG & Co. KGaA

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution